Healthcare stocks declined late Thursday afternoon, with the NYSE Healthcare Index and the State Street Health Care Select Sector SPDR ETF (XLV) each shedding 1.1%.
The iShares Biotechnology ETF (IBB) was down 0.1%.
In corporate news, NeoGenomics (NEO) shares jumped nearly 8% after the company said its RaDaR ST molecular residual disease assay received expanded Medicare coverage to include immunotherapy response monitoring for patients with late-stage solid tumors.